SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007702
Filing Date
2019-08-08
Accepted
2019-08-08 16:12:01
Documents
62
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q omer-20190630x10q.htm   iXBRL 10-Q 1065107
2 EX-10.1 omer-20190630ex101471e07.htm EX-10.1 47971
3 EX-31.1 omer-20190630ex311cce026.htm EX-31.1 13503
4 EX-31.2 omer-20190630ex312b3458e.htm EX-31.2 15517
5 EX-32.1 omer-20190630ex321978b69.htm EX-32.1 10606
6 EX-32.2 omer-20190630ex3221d308d.htm EX-32.2 8676
7 GRAPHIC omer-20190630x10q007.jpg GRAPHIC 28832
  Complete submission text file 0001558370-19-007702.txt   5404204

Data Files

Seq Description Document Type Size
8 EX-101.SCH omer-20190630.xsd EX-101.SCH 32609
9 EX-101.CAL omer-20190630_cal.xml EX-101.CAL 59148
10 EX-101.DEF omer-20190630_def.xml EX-101.DEF 89592
11 EX-101.LAB omer-20190630_lab.xml EX-101.LAB 372300
12 EX-101.PRE omer-20190630_pre.xml EX-101.PRE 259370
13 EXTRACTED XBRL INSTANCE DOCUMENT omer-20190630x10q_htm.xml XML 1063929
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 191009631
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences